SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Catamaran Corporation - CTRX

BALA CYNWYD, Pa., March 31, 2015 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Catamaran Corporation ("Catamaran" or "the Company") (Nasdaq-CTRX-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to United Health Group, Inc.'s OptumRX, Inc. ("OptumRX").

Click here to learn more about the investigation http://brodsky-smith.com/909-ctrx-catamaran-corporation.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Catamaran shareholders will receive only $61.50 in cash for each share of Catamaran stock they own. The investigation concerns whether the Board of Catamaran breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether OptumRX is underpaying for Catamaran.

The transaction may undervalue Catamaran which has robust revenue growth, a solid financial position with reasonable debt levels, an increased stock price during the past year, earnings per share growth, and growth in net income. In addition, Catamaran's business is expected to benefit from an aging U.S. population, prevalence of chronic disease, increased life expectancy, and raising pharmaceutical costs. As a result an analyst has set a $66.00 per share price target for Catamaran stock.  

If you own shares of Catamaran stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, by visiting http://brodsky-smith.com/909-ctrx-catamaran-corporation.html, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-catamaran-corporation---ctrx-300058973.html

SOURCE Brodsky & Smith, LLC

Copyright 2015 PR Newswire